Literature DB >> 28621541

Expanding the Scope of Electrophiles Capable of Targeting K-Ras Oncogenes.

Lynn M McGregor1, Meredith L Jenkins2, Caitlin Kerwin1, John E Burke2, Kevan M Shokat1.   

Abstract

There is growing interest in reversible and irreversible covalent inhibitors that target noncatalytic amino acids in target proteins. With a goal of targeting oncogenic K-Ras variants (e.g., n class="Mutation">G12D) by expanding the types of amino acids that can be targeted by covalent inhibitors, we survey a set of electrophiles for their ability to label carboxylates. We functionalized an optimized ligand for the K-Ras switch II pocket with a set of electrophiles previously reported to react with carboxylates and characterized the ability of these compounds to react with model nucleophiles and oncogenic K-Ras proteins. Here, we report that aziridines and stabilized diazo groups preferentially react with free carboxylates over thiols. Although we did not identify a warhead that potently labels K-Ras G12D, we were able to study the interactions of many electrophiles with K-Ras, as most of the electrophiles rapidly label K-Ras G12C. We characterized the resulting complexes by crystallography, hydrogen/deuterium exchange, and differential scanning fluorimetry. Our results both demonstrate the ability of a noncatalytic cysteine to react with a diverse set of electrophiles and emphasize the importance of proper spatial arrangements between a covalent inhibitor and its intended nucleophile. We hope that these results can expand the range of electrophiles and nucleophiles of use in covalent protein modulation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28621541      PMCID: PMC5665167          DOI: 10.1021/acs.biochem.7b00271

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

Review 1.  Covalent targeting of acquired cysteines in cancer.

Authors:  Marieke Visscher; Michelle R Arkin; Tobias B Dansen
Journal:  Curr Opin Chem Biol       Date:  2015-11-28       Impact factor: 8.822

2.  Optimized diazo scaffold for protein esterification.

Authors:  Kalie A Mix; Ronald T Raines
Journal:  Org Lett       Date:  2015-05-04       Impact factor: 6.005

3.  Disparate proteome reactivity profiles of carbon electrophiles.

Authors:  Eranthie Weerapana; Gabriel M Simon; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-05-18       Impact factor: 15.040

Review 4.  The resurgence of covalent drugs.

Authors:  Juswinder Singh; Russell C Petter; Thomas A Baillie; Adrian Whitty
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

Review 5.  Covalent protein modification: the current landscape of residue-specific electrophiles.

Authors:  D Alexander Shannon; Eranthie Weerapana
Journal:  Curr Opin Chem Biol       Date:  2014-11-11       Impact factor: 8.822

6.  Ligand-directed acyl imidazole chemistry for labeling of membrane-bound proteins on live cells.

Authors:  Sho-hei Fujishima; Ryosuke Yasui; Takayuki Miki; Akio Ojida; Itaru Hamachi
Journal:  J Am Chem Soc       Date:  2012-02-24       Impact factor: 15.419

7.  Structural Dynamics in Ras and Related Proteins upon Nucleotide Switching.

Authors:  Rane A Harrison; Jia Lu; Martin Carrasco; John Hunter; Anuj Manandhar; Sudershan Gondi; Kenneth D Westover; John R Engen
Journal:  J Mol Biol       Date:  2016-10-14       Impact factor: 5.469

8.  Mapping Protein-Ligand Interactions with Proteolytic Fragmentation, Hydrogen/Deuterium Exchange-Mass Spectrometry.

Authors:  Elyssia S Gallagher; Jeffrey W Hudgens
Journal:  Methods Enzymol       Date:  2015-10-23       Impact factor: 1.600

9.  An orthosteric inhibitor of the Ras-Sos interaction.

Authors:  Anupam Patgiri; Kamlesh K Yadav; Paramjit S Arora; Dafna Bar-Sagi
Journal:  Nat Chem Biol       Date:  2011-07-17       Impact factor: 15.040

10.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

View more
  13 in total

Review 1.  Dynamic structural biology at the protein membrane interface.

Authors:  John E Burke
Journal:  J Biol Chem       Date:  2019-01-28       Impact factor: 5.157

2.  Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States.

Authors:  Daniel R Gentile; Manoj K Rathinaswamy; Meredith L Jenkins; Steven M Moss; Braden D Siempelkamp; Adam R Renslo; John E Burke; Kevan M Shokat
Journal:  Cell Chem Biol       Date:  2017-10-12       Impact factor: 8.116

3.  Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange.

Authors:  Chimno I Nnadi; Meredith L Jenkins; Daniel R Gentile; Leslie A Bateman; Daniel Zaidman; Trent E Balius; Daniel K Nomura; John E Burke; Kevan M Shokat; Nir London
Journal:  J Chem Inf Model       Date:  2018-01-31       Impact factor: 4.956

4.  On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.

Authors:  Vinicius Bonatto; Pedro Henrique Jatai Batista; Lorenzo Cianni; Daniela De Vita; Daniel G Silva; Rodrigo Cedron; Daiane Y Tezuka; Sérgio de Albuquerque; Carolina Borsoi Moraes; Caio Haddad Franco; Jerônimo Lameira; Andrei Leitão; Carlos A Montanari
Journal:  RSC Med Chem       Date:  2020-09-09

5.  KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation.

Authors:  Jia Lu; Asim K Bera; Sudershan Gondi; Kenneth D Westover
Journal:  Biochemistry       Date:  2017-12-28       Impact factor: 3.162

Review 6.  Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers.

Authors:  Emily N Arner; Wenting Du; Rolf A Brekken
Journal:  Front Oncol       Date:  2019-10-11       Impact factor: 6.244

Review 7.  Structure-based inhibitor design of mutant RAS proteins-a paradigm shift.

Authors:  Kinga Nyíri; Gergely Koppány; Beáta G Vértessy
Journal:  Cancer Metastasis Rev       Date:  2020-12       Impact factor: 9.264

8.  WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.

Authors:  Andrea Scarpino; László Petri; Damijan Knez; Tímea Imre; Péter Ábrányi-Balogh; György G Ferenczy; Stanislav Gobec; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2021-01-18       Impact factor: 3.686

9.  Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo.

Authors:  Kotaro Sakamoto; Teruaki Masutani; Takatsugu Hirokawa
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

10.  Quantitative Systems Pharmacology Analysis of KRAS G12C Covalent Inhibitors.

Authors:  Edward C Stites; Andrey S Shaw
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.